*ST吉药
(300108)
| 流通市值：6.95亿 | | | 总市值：7.06亿 |
| 流通股本：6.56亿 | | | 总股本：6.66亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 254,832,693.5 | 167,177,993.62 | 75,460,849.87 | 346,106,530.05 |
| 营业收入 | 254,832,693.5 | 167,177,993.62 | 75,460,849.87 | 346,106,530.05 |
| 二、营业总成本 | 448,087,921.36 | 281,673,699.73 | 126,726,415.45 | 629,393,441.09 |
| 营业成本 | 160,410,129.72 | 113,211,275.57 | 51,531,566.54 | 241,450,337.16 |
| 税金及附加 | 10,235,725.9 | 6,992,934.88 | 2,796,811.6 | 12,076,309.24 |
| 销售费用 | 62,324,597.87 | 22,558,294.28 | 6,684,934.46 | 70,077,949.23 |
| 管理费用 | 79,659,680.68 | 47,224,795.79 | 25,018,694.71 | 134,704,854.38 |
| 研发费用 | 5,307,154.95 | 4,160,753.5 | 1,986,968.57 | 12,944,883.74 |
| 财务费用 | 130,150,632.24 | 87,525,645.71 | 38,707,439.57 | 158,139,107.34 |
| 其中:利息费用 | 122,790,746.96 | 81,005,893.23 | 33,485,776.87 | 157,415,082.41 |
| 其中:利息收入 | 81,915.36 | 20,759.28 | 8,073.56 | 248,346.78 |
| 加:投资收益 | 467,149.89 | 41,069.89 | 20,723.92 | 17,947,849.51 |
| 资产处置收益 | 587,478.32 | 587,478.32 | 587,478.32 | 6,440,272.29 |
| 资产减值损失(新) | -43,913,014.14 | -25,120,188 | - | -80,001,418.55 |
| 信用减值损失(新) | -21,063,490.82 | -26,248,143.78 | - | -13,204,572.8 |
| 其他收益 | 956,135.24 | 668,696.39 | 306,713.63 | 5,312,685.48 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -256,220,969.37 | -164,566,793.29 | -50,350,649.71 | -346,792,095.11 |
| 加:营业外收入 | 148,741.57 | 36,130.42 | 30,838.42 | 106,996.56 |
| 减:营业外支出 | 31,005,098.46 | 11,993,566.13 | 6,293,321.95 | 95,699,380.73 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -287,077,326.26 | -176,524,229 | -56,613,133.24 | -442,384,479.28 |
| 减:所得税费用 | 6,882,381.73 | 4,589,711.49 | 3,889,536.97 | 3,520,737.73 |
| 六、净利润 | -293,959,707.99 | -181,113,940.49 | -60,502,670.21 | -445,905,217.01 |
| 持续经营净利润 | -293,959,707.99 | -181,113,940.49 | -60,502,670.21 | -445,905,217.01 |
| 归属于母公司股东的净利润 | -231,236,923.98 | -138,531,220.67 | -40,853,954.75 | -349,309,644.16 |
| 少数股东损益 | -62,722,784.01 | -42,582,719.82 | -19,648,715.46 | -96,595,572.85 |
| (一)基本每股收益 | -0.35 | -0.21 | -0.06 | -0.52 |
| (二)稀释每股收益 | -0.35 | -0.21 | -0.06 | -0.52 |
| 八、其他综合收益 | - | - | - | -8,299,576.45 |
| 归属于母公司股东的其他综合收益 | - | - | - | -8,299,576.45 |
| 九、综合收益总额 | -293,959,707.99 | -181,113,940.49 | -60,502,670.21 | -454,204,793.46 |
| 归属于母公司股东的综合收益总额 | -231,236,923.98 | -138,531,220.67 | -40,853,954.75 | -357,609,220.61 |
| 归属于少数股东的综合收益总额 | -62,722,784.01 | -42,582,719.82 | -19,648,715.46 | -96,595,572.85 |
| 公告日期 | 2024-10-30 | 2024-08-27 | 2024-04-29 | 2024-04-29 |
| 审计意见(境内) | | | | 无法表示意见 |